US And UK Senior Care Demand Will Sustain Future Expansion

Published
25 Aug 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$41.00
0.02% overvalued intrinsic discount
14 Aug
US$41.01
Loading
1Y
9.6%
7D
2.7%

Author's Valuation

US$41.0

0.02% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Increased 24%

Shared on30 Apr 25
Fair value Decreased 4.78%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 17%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.1%.

Shared on17 Apr 25
Fair value Decreased 0.17%

AnalystConsensusTarget has decreased revenue growth from -0.3% to -0.6%.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 0.17%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.17%

AnalystConsensusTarget has increased revenue growth from -0.1% to -0.3%, increased profit margin from 41.4% to 51.0% and decreased future PE multiple from 42.0x to 34.3x.

Shared on10 Mar 25
Fair value Increased 4.34%

AnalystConsensusTarget has decreased revenue growth from -2.3% to -0.1%, decreased profit margin from 50.0% to 41.4% and increased future PE multiple from 28.9x to 42.0x.